Rachele Niccolai

In January 2021, I obtained my master’s degree in Biotechnology and Medical Biology at Vita-Salute San Raffaele University (Milan). As part of the master program, I performed my internship at The Institute of Molecular Oncology (IFOM), studying the epigenetic resistance of B cell receptor inhibitors in MYC-driven lymphoma cells.

In line with the epigenetics and immunology studies, I joined the Heinz Jacobs group as a PhD student, in May 2021. Here, in collaboration with the Fred van Leeuwen group, my main focus is to understand the dependency of GC B cells on the epigenetic writer DOT1L.